250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Finland in July 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Finland. We rank investors based on the number of investments they made in Medical companies from Finland. We update this investor list every month.

Top 50 Medical Startup Investors in Finland in July 2025

Investor Medical Finland investments
Finnvera Venture Capital 7
Business Finland 7
Voima Ventures 6
Lifeline Ventures 5
Maki.vc 4
Innovestor 3
Reaktor Ventures 3
Butterfly Ventures 3
Icebreaker.vc 3
Inventure 2
Vesalius Biocapital Partners 2
Novo Holdings 2
Metsola Ventures 2
Anssi Vanjoki 2
Springvest 2
Jyri Engestrom 2
Samsung Venture Investment 2
Karolinska 2
Kustaa Piha 1
Metaplanet 1
Marten Mickos 1
Asko Schrey 1
Athensmed 1
Lynx Capital 1
Ananda Impact Ventures 1
MVM Life Science Partners 1
Cascara Ventures 1
Esther Dyson 1
Nordic Science Investments 1
M Ventures 1
Novartis Venture Fund 1
Capricorn Partners 1
Way to Wellville 1
Jukka Tapaninen 1
Cor Group 1
Torrey Pines Investment 1
J12 1
DigiTx Partners 1
Ali Omar 1
Gaingels 1
Hadean Ventures 1
Korpun Siemen 1
XR Invest 1
Petri Pöyhönen 1
Sunstone Life Science Ventures 1
Visionplus 1
SHS Capital 1
Sandwater 1
Noaber 1
HTGF (High-Tech Gruenderfonds) 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Finnvera Venture Capital VC Fund · Kuopio, Eastern Finland, Finland
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Finland, United States, Switzerland
Portfolio highlights
  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Business Finland VC Fund · Helsinki, Southern Finland, Finland · 20 investments in the past 12 months
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Grant, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • AIATELLA — Automating medical image analysis
  • SparkReceipt — AI-powered Receipt Scanner and Expense Tracker for Individuals and Small Businesses. Create your free account now!
  • University of Eastern Finland — The University of Eastern Finland is a multidisciplinary university which offers teaching in more than 100 major subjects. The university comprises four faculties: the Philosophical Faculty, the Faculty of Science and Forestry, the Faculty of Health Sciences, and the Faculty of Social Sciences and Business Studies.
Voima Ventures VC Fund · Helsinki, Southern Finland, Finland · 11 investments in the past 12 months
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Seed, Pre-Seed, Funding Round
  • Finland, Sweden, Norway
Portfolio highlights
  • Hormona — Understand your hormones with the Hormona app. Monitor hormone levels, track symptoms, forecast cycles, and access personalized wellness tips for a balanced life.
  • Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Lifeline Ventures VC Fund · Helsinki, Southern Finland, Finland · 14 investments in the past 12 months
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Series A, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • Swarmia — Build better software faster with insights that power your whole engineering organization. Get started with a demo or a free 14-day trial.
  • Inven — Save time by using AI to find companies. Inven scans millions of websites to provide comprehensive data on companies similar to your search criteria.
  • Ovido — Ovido company specialises in supply chain and product data automation, with a focus on providing full product traceability and the establishment of Digital Product Passports (DPPs).
Maki.vc VC Fund · Helsinki, Southern Finland, Finland · 14 investments in the past 12 months
Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Funding Round
  • Finland, Norway, Denmark
Portfolio highlights
  • Ever Dye — A new standard for dyes. Naturally made, carbon emissions reducing, water protecting.
  • ONiO — ONiO is a fabless IoT company specializing in batteryless microcontrollers that run on ambient energy. ONiO.zero can use virtually any RF, thermal, solar, piezo signal as a power source. Our aim is to unshackle one IoT device at a time from the battery, en route to a 100% battery-free IoT future. Our product offers manufacturers a more minimalist, user-friendly, economical and environmentally sustainable power solution for IoT devices.
  • deepdots — Magic Feedback is an AI business creating a platform that compiles user reviews into one location and analyzes everything automatically using its own AI.
Innovestor VC Fund · Helsinki, Southern Finland, Finland · 10 investments in the past 12 months
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more
Investment focus
  • Software, Health Care, Manufacturing
  • Seed, Funding Round, Series A
  • Finland, Denmark, Sweden
Portfolio highlights
  • Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
  • Bahn Express — Fast and Effortless Car Transport
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Reaktor Ventures VC Fund · Helsinki, Southern Finland, Finland
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more
Investment focus
  • Software, Internet, Health Care
  • Seed, Pre-Seed, Series A
  • Finland, Germany, United States
Portfolio highlights
  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
  • Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Butterfly Ventures VC Fund · Oulu, Oulu, Finland · 4 investments in the past 12 months
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Finland, Sweden, Norway
Portfolio highlights
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Brightplus Oy — Brightplus is an innovative renewable materials manufacturing company from Finland. We specialise in design and development of new functional properties for industrial biomaterial solutions. We cater for industries like packaging, construction, cosmetics and consumer goods. Our expertise is based on developing solutions to multiple industries andproviding fast prototyping and full fit for customers’ production lines. Our deep chemical BrightBio® technology creates an optimal fit between coatings, barriers and plastic replacing materials to help you in raising your material functionality to the next level.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Icebreaker.vc VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • Finland, Estonia, Sweden
Portfolio highlights
  • Aibidia — Discover the Aibidia TXM Platform and our digital transfer pricing applications, eliminating billions of euros in tax inefficiencies and risks.
  • Crewpoint — Crewpoint specially designed tools that are adapted to the intricacies of maritime logistics our platform streamlines crew movements. We assist operations teams in providing seamless, effective staff changes worldwide, from bulk reservations and last-minute reroutes to round-the-clock assistance and real-time travel statistics.
  • Clock & Cloud — AI-driven platform delivering actionable geopolitical intelligence for proactive decision-making and enhanced business security
Inventure VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • Finland, Sweden, Denmark
Portfolio highlights
  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
  • Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Vesalius Biocapital Partners VC Fund · Strassen, Luxembourg, Luxembourg · 5 investments in the past 12 months
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, Germany, The Netherlands
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 29 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
  • Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
  • Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Metsola Ventures VC Fund · Espoo, Southern Finland, Finland
Metsola Ventures
Show more
Investment focus
  • Medical, mHealth, Health Care
  • Series A
  • Finland
Portfolio highlights
  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Anssi Vanjoki Angel · Helsinki, Southern Finland, Finland
As Executive Vice President and General Manager of Multimedia, Nokia, Anssi Vanjoki heads a business group that is responsible for developing Nokia Nseries multimedia computers and associated experiences and services. This fast growing segment of consumer electronics will shape our lives in a fundamental way. A highly respected brand authoritywith over 25 years of marketing experience, Anssi has been a driving force in Nokia's efforts to address the mobile markets. His work has focused on developing Nokia's brand durability, loyalty and continuity, while, at the same time, advancing Nokia's vision of a mobile world. Anssi joined Nokia in 1991 and was named Vice President, Sales, Nokia Mobile Phones, before his promotion in 1994 to Senior Vice President, Nokia Mobile Phones Europe and Africa. In 1998 he was made Executive Vice President, Nokia Mobile Phones Europe and Africa and became a member of the Group Executive Board of Nokia. In addition, in 1999, Anssi took responsibility for Nokia's Digital Convergence Unit and, in 2002, also headed up the Business Unit Management. He was appointed to his present position on January 1st 2004. Prior to joining Nokia, Anssi held a variety of management positions at 3M Corporation. Anssi is the Chairman of the Board of Amer Group, and was a member of the Governing Committee of the European Foundation for Quality Management 2001 - 2003. He is a Knight, 1st Class, of the Order of the White Rose of Finland. Anssi holds a master's degree in economics from the Helsinki School of Economics and Business Administration.
Show more
Investment focus
  • Medical, Hardware, Health Care
  • Angel, Series A
  • Finland
Portfolio highlights
Springvest VC Fund · Helsinki, Southern Finland, Finland
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Series A, Funding Round, Seed
  • Finland
Portfolio highlights
  • Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Jyri Engestrom Angel · San Francisco, California, United States
Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more
Investment focus
  • Software, E-Commerce, Apps
  • Seed, Pre-Seed, Series A
  • United States, Finland, Canada
Portfolio highlights
  • Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
  • Spell — Operationalizing AI for NLP, Computer Vision, and Speech Recognition has never been easier
  • Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
Samsung Venture Investment VC Fund · Seocho, Seoul-t'ukpyolsi, South Korea · 5 investments in the past 12 months
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Series A, Series B, Seed
  • South Korea, United States, India
Portfolio highlights
  • wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
  • Medisolar — Medisol is a food technology firm that also provides personalized food care solutions.
  • C2N Diagnostics — C2N Diagnostics, LLC is a privately held protein diagnostic and therapeutic discovery company targeting progressive neurodegeneration. They formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, and LifeTech Research, a Maryland-based technology research andcommercialization firm (www.lifetechresearch.com). They reside at the Center for Emerging Technologies in St. Louis.
Karolinska VC Fund · Solna, Stockholms Lan, Sweden
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Seed, Series A
  • Sweden, Denmark, United States
Portfolio highlights
  • PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
  • OssDsign AB — Giving patients back the life they deserve, Catalyst nanosynthetic bone graft, orthobiologics
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Kustaa Piha Angel · Helsinki, Southern Finland, Finland
Healthcare business development, management, and investing. Very good knowledge on healthcare services and public health. Kustaa Piha is interested in new business and investment opportunities and better ways of producing excellent healthcare services.
Show more
Investment focus
  • Health Care, Health Diagnostics, Medical Device
  • Seed, Funding Round
  • Finland
Portfolio highlights
  • Sooma — Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.
  • Klinik — Klinik® is an innovative health website designed from the very beginning to meet the needs of users. They offer advanced tools for consumers to identify their conditions and to treat them properly, and if needed, they connect them with matching health professionals. It’s a unique platform for health experts to show their true expertise toconsumers. Main characteristics of their offering are:1) Easy access to qualified and reliable health and medical information2) Helping people to identify their conditions3) Providing people valid evidence-based info on self care4) Integrating professional healthcare providers with users requesting additional medical.
  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Metaplanet VC Fund · Tallinn, Harjumaa, Estonia · 9 investments in the past 12 months
an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.
Show more
Investment focus
  • Artificial Intelligence, Software, Machine Learning
  • Seed, Series A, Series B
  • United States, United Kingdom, Estonia
Portfolio highlights
  • Aerones — Robotic wind turbine service company offering maintenance, inspection and repairs worldwide. Reduce downtime and improve the efficiency of your wind park
  • Parallel Bio — Using the immune system to cure disease. Parallel Bio uses a human immune system in a dish and AI to discover drugs more likely to work in patients.
  • Atrandi Biosciences — Achieve your discoveries easier using high-throughput screening and droplet microfluidics. Create your own custom workflows for any R&D or academic applications.
Marten Mickos Angel · San Francisco, California, United States
Marten Mickos is the CEO of HackerOne, Inc. the leading vulnerability coordination and bug bounty platform. Previously Marten was the CEO of Eucalyptus Systems, acquired by Hewlett-Packard where he served as head of the cloud business. As the CEO of MySQL AB from 2001 to 2008, Marten grew that company from a garage start-up to the second largestopen source company in the world. Marten holds a M.Sc. in technical physics from Helsinki University of Technology in his native Finland.
Show more
Investment focus
  • Software, Enterprise Software, Internet
  • Seed, Series A, Convertible Note
  • United States, Finland, Sweden
Portfolio highlights
  • Queer Spaces — Spaces is a group chat platform for building queer communities, and the first app to serve the entirety of the LGBTQ+ spectrum.
  • ArcticStartup — ArcticStartup is the leading startup news publication covering the Nordics and Baltics delivering the latest insights on the hottest startups in the region
  • Pandatron — With clients like SAP, Universal Pictures & Skanska, Pandatron is a startup that supports change management. We do it by scaling AI-driven coaching 1-on-1s to every employee, which also allows us to measure change.
Asko Schrey Angel
Asko Schrey
Show more
Investment focus
  • Medical, Health Care, Machine Learning
  • Seed
  • Finland
Portfolio highlights
  • Zefort — Zefort is a powerful contract management software. Sign, store, share contracts and easily with your team. Set reminders and use a powerful search.
  • MVision AI — Combining human expertise with the power of AI for efficient and high-impact radiotherapy.
  • ReceiptHero — Say goodbye to paper receipts. Cut operational costs, reduce waste and deliver a better in-store experience for customers.
Athensmed VC Fund
Athensmed Oy
Show more
Investment focus
  • Health Care, Medical, mHealth
  • Seed, Series A, Funding Round
  • Finland
Portfolio highlights
  • VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Lynx Capital VC Fund · Shanghai, Shanghai, China
cross-border, healthcare, life science, investment, VC, China, US
Show more
Investment focus
  • Therapeutics, Biotechnology, Pharmaceutical
  • Series A
  • Finland
Portfolio highlights
  • Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Ananda Impact Ventures VC Fund · Munich, Bayern, Germany · 6 investments in the past 12 months
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Germany, United Kingdom, Finland
Portfolio highlights
  • Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
  • Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
  • NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!
MVM Life Science Partners VC Fund · London, England, United Kingdom
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Series B, Series C
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
  • Gynesonics — Gynesonics is a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions. Gynesonics serves customers worldwide. It was founded in 2005 and is headquartered in Redwood City, California.
  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
Cascara Ventures VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Seed, Series B
  • Germany, Finland, The Netherlands
Portfolio highlights
  • Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
  • ATRO Medical — ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype.
  • microDimensions — microDimensions provides digital pathology software and services: image analysis, 3D histology reconstruction, protein multiplexing, stereology, image registration.
Esther Dyson Angel · New York, New York, United States
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Funding Round
  • United States, Canada, Russian Federation
Portfolio highlights
  • Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
  • Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Nordic Science Investments VC Fund · 7 investments in the past 12 months
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more
Investment focus
  • Apps, Food Processing, Food and Beverage
  • Seed
  • Finland
Portfolio highlights
  • AIATELLA — Automating medical image analysis
  • Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
  • SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 16 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • Biolinq — Introducing a revolutionary platform for metabolic health.
  • ChEmpower — ChEmpower is an advanced materials company that develops chemically reactive, abrasive-free planarization pads to improve chip yields and sustainability in semiconductor manufacturing.
  • Corvic AI — Corvic AI is pioneering a new era of Data-Centric AI Cognitive Infrastructure by transforming raw enterprise data into AI-ready intelligence.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 9 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Capricorn Partners VC Fund · Leuven, Vlaams-Brabant, Belgium · 5 investments in the past 12 months
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands
Portfolio highlights
  • InsectSense — MIMICKING HOW INSECTS SENSE | Biomimetic technology based on the sensing mechanism of insects. A deeptech platform that applies synthetic biology, microfluidics and is powered by machine learning.
  • Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
  • Econic Technologies — At Econic, we are pioneering the transformation of CO2 into high-performance materials that shape a better future for all.
Way to Wellville VC Fund · Astoria, Oregon, United States
Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.
Show more
Investment focus
  • Software, Health Care, Medical
  • Funding Round, Series B, Series A
  • United States, Finland
Portfolio highlights
  • Upbeat — Upbeat is a software-powered next-generation PR agency that focuses on media marketing for various companies. The company is a team of software engineers and PR professionals working together to bring the old-school PR industry to the modern world. Upbeat turns story ideas to into something presentable by connecting the best stories to the beststorytellers. They also manage email outreach and follow-ups and keep track of pitch's progress with real-time analytics and email updates. And, its software is also an avenue to monitor media opportunities on company's behalf.
  • Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
Jukka Tapaninen Angel
Jukka Tapaninen is an experienced IT business executive and a board member at Fimmic. Jukka also holds board positions at weVision, Addoro Ab, Findity and MeshWorks Wireless Oy.Jukka has a strong background in the IT industry on managing companies and business units globally. His leadership experience, from large companies like SAP and HP, aswell as from strong midsize companies has given him industry knowledge and excellent network within the strategic ecosystem and major customers. Jukka has experience in working in the United States, Singapore and multiple locations in Europe that have given him a good understanding on how business is done in different parts of the world.Jukka holds a M.Sc. degree from the Helsinki School of Economics.
Show more
Investment focus
  • Medical, Software, Education
  • Seed
  • Finland
Portfolio highlights
  • Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
Cor Group VC Fund · Oulu, Oulu, Finland
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Pre-Seed, Series A
  • Finland
Portfolio highlights
  • Gosta Labs — Focus on care
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Nightingale Health — The most advanced health check for the health industry.
Torrey Pines Investment VC Fund · San Diego, California, United States · 5 investments in the past 12 months
Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Funding Round, Series A
  • United States, Russian Federation, Canada
Portfolio highlights
  • Mair Therapeutics — Mair Therapeutics main goal is finding and creating a small-molecule ion channel activator to treat Parkinson's disease, a preclinical drug discovery business.
  • Lomond Therapeutics — Targeting escape mutations in hematological cancers with first and best in class medicines.
  • MAIR PHARMACEUTICALS — Mair Pharmaceutical creates innovative processes and produces well-known unique substances for pharmaceutical and biopharmaceutical firms worldwide.
J12 VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in the past 12 months
We back founders early building for the AI era. Founders building software infrastructure that makes data more accessible, and AI applications for enterprises, consumers, and healthcare. But most importantly still, founders with outlier ingenuity, childish curiosity, and the stamina to prevail.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Series A
  • Sweden, Germany, Norway
Portfolio highlights
  • Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
  • Pistachio — Pistachio is a fully automated cybersecurity awareness training and attack simulation platform.
  • IPercept — At IPercept we provide AI-based, hardware-enabled software solutions and services that can best be described as the fitness tracker for complex industrial machines. At the push of a button, you can learn about a machines’ health, down to micrometer changes for each critical component. You can get insights into what maintenance activities you shouldapply and when. You can monitor how the machines are operated, how to optimize their utilization and much more. All of this is achieved through a plug-n-play installation - for old machines as well as new. All securely provided without requiring access to any machine controllers or IT-systems. These services reduce maintenance costs, downtime and increase productivity - a solid ROI for our customers. In 5 years, most complex industrial machinery sold in the world will be supported by our technology.
DigiTx Partners VC Fund · Brisbane, California, United States
At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcareecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Series A, Seed, Series B
  • United States, Canada, Finland
Portfolio highlights
  • StrokeDx — Boldly transforming how strokes are diagnosed with innovative, rapid, and portable devices. StrokeDx develops next-generation point-of-care stroke diagnostic technologies to reduce the time to treatment in acute stroke care and triage.
  • CardioSignal — Access information about your heart health in just one minute using your phone.
  • Cerula Care — Cerula Care specializes in behavioral health services for people with chronic conditions.
Ali Omar Angel · Helsinki, Southern Finland, Finland
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Pre-Seed, Angel
  • Finland, United States, Estonia
Portfolio highlights
  • Themo — Themo's innovation is an algorithm that optimizes the price of exchange electricity and the consumption of electricity. Themo offers an easy and environmentally friendly way to save on electricity consumed by heating.
  • GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
  • Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
Gaingels VC Fund · New York, New York, United States · 40 investments in the past 12 months
Gaingels is a leading venture investment syndicate in support of diversity, inclusive of the LGBTQIA+ community and allies in the venture capital space.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, Canada, Mexico
Portfolio highlights
  • Nava — Nava Benefits is a modern employee benefits brokerage leveraging technology and benefits innovation to tackle the rising costs of healthcare.
  • Akash Systems — Akash is a pioneer in thermal management, offering solutions that set the global standard for technology.
  • Galileo — Galileo provides high-touch, data-driven, multi-specialty, longitudinal care to a diverse and complex patient population—over the phone, at home, and everywhere in between. Regional and national health plans, employers, and Fortune 500 companies all regard Galileo as the leading solution for improving population health. It aims to use that talentand scientific thinking to transform society by solving the most difficult healthcare problems while also bringing patients and providers closer together.
Hadean Ventures VC Fund · Oslo, Oslo, Norway
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Funding Round, Series B
  • Sweden, Norway, Austria
Portfolio highlights
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Korpun Siemen VC Fund · Oulu, Oulu, Finland · 2 investments in the past 12 months
Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.
Show more
Investment focus
  • Software, Information Technology, Pet
  • Seed, Funding Round, Angel
  • Finland
Portfolio highlights
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
  • Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
XR Invest VC Fund
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more
Investment focus
  • Medical Device, Sensor, Medical
  • Series A, Series C, Funding Round
  • Finland, United States
Portfolio highlights
  • Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Petri Pöyhönen Angel · Helsinki, Southern Finland, Finland
Petri Pöyhönen
Show more
Investment focus
  • Medical, Biotechnology, Medical Device
  • Series A
  • Finland
Portfolio highlights
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Sunstone Life Science Ventures VC Fund · Copenhagen, Hovedstaden, Denmark
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series A
  • Denmark, Sweden, Switzerland
Portfolio highlights
  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Visionplus VC Fund · Helsinki, Southern Finland, Finland
WE HELP YOU TO GROW FASTER!
Show more
Investment focus
  • Software, Information Technology, Internet
  • Seed, Funding Round, Series A
  • Finland, United States, United Kingdom
Portfolio highlights
  • Pebble — Pebble is a electric vehicle manufacturing startup.
  • Transfluent — Professional translations for all business needs. Fast. Easy.
  • BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
SHS Capital VC Fund · Tübingen, Baden-Wurttemberg, Germany
Mission With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions. Located in the …
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Funding Round, Series C, Series A
  • Germany, Switzerland, France
Portfolio highlights
  • MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
  • Simulands — Human grade cardiovascular simulators
  • ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
Sandwater VC Fund · Oslo, Oslo, Norway · 2 investments in the past 12 months
We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.
Show more
Investment focus
  • Apps, AgTech, Energy
  • Series A, Seed
  • Norway, Finland
Portfolio highlights
  • Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
  • CardioSignal — Access information about your heart health in just one minute using your phone.
Noaber VC Fund · Lunteren, Gelderland, The Netherlands
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more
Investment focus
  • Health Care, Medical, Fitness
  • Seed, Series A, Funding Round
  • The Netherlands, Israel, Sweden
Portfolio highlights
  • Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
  • Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
HTGF (High-Tech Gruenderfonds) VC Fund · Bonn, Nordrhein-Westfalen, Germany · 34 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
  • nuuEnergy — nuuEnergy is a tech-enabled solution aiming to revolutionize the heat pump installation industry. By leveraging technology and industry expertise, we streamline the purchasing and installation process. Our unique approach, refinanced through innovative strategies, promotes a self-reliant and carbon-neutral lifestyle for all our customers.
  • Steuerboard — Steuerboard serves as a collaborative platform facilitating digital interaction between tax advisors and clients. The mission of Steuerboard is to rethink the way accountants and clients work together.
Investors by industry
Investors by country
Investors in Finland by industry